ARCHIVES

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002